Mathieu Gerfaud‐Valentin

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

Sophie Georgin‐Lavialle, Benjamin Terrier, Alexis F. Guédon et al. · British Journal of Dermatology · 2021 · 387 citations · Full text

Adult-Onset Still Disease

Mathieu Gerfaud‐Valentin, Delphine Maucort‐Boulch, A. Hot et al. · Medicine · 2014 · 238 citations · Full text

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster et al. · Blood · 2022 · 194 citations · Full text

Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis

Yvan Jamilloux, Delphine Maucort‐Boulch, Sébastien Kerever et al. · European Respiratory Journal · 2016 · 118 citations · Full text

Epidemiological Trend, Mortality Studies, Epidemiological Outcome +12

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

Matthieu Mahévas, Mathieu Gerfaud‐Valentin, Guillaume Moulis et al. · Blood · 2016 · 97 citations · Full text